vs
NexPoint Real Estate Finance, Inc.（NREF）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是Arcus Biosciences, Inc.的1.0倍（$11.1M vs $11.0M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -963.6%，领先1180.3%），NexPoint Real Estate Finance, Inc.同比增速更快（-48.8% vs -52.2%）
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
NREF vs RCUS — 直观对比
营收规模更大
NREF
是对方的1.0倍
$11.0M
营收增速更快
NREF
高出3.3%
-52.2%
净利率更高
NREF
高出1180.3%
-963.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $11.0M |
| 净利润 | $24.0M | $-106.0M |
| 毛利率 | — | — |
| 营业利润率 | — | -1036.4% |
| 净利率 | 216.6% | -963.6% |
| 营收同比 | -48.8% | -52.2% |
| 净利润同比 | 58.7% | -12.8% |
| 每股收益（稀释后） | $0.47 | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NREFRCUS
| Q4 25 | $11.1M | $11.0M | ||
| Q3 25 | $12.5M | $6.0M | ||
| Q2 25 | $12.1M | $8.0M | ||
| Q1 25 | $11.5M | $8.0M | ||
| Q4 24 | $21.7M | $23.0M | ||
| Q3 24 | $12.5M | $7.0M | ||
| Q2 24 | $6.7M | $11.0M | ||
| Q1 24 | $-12.8M | $10.0M |
净利润NREFRCUS
| Q4 25 | $24.0M | $-106.0M | ||
| Q3 25 | $50.9M | $-135.0M | ||
| Q2 25 | $22.3M | $0 | ||
| Q1 25 | $26.0M | $-112.0M | ||
| Q4 24 | $15.2M | $-94.0M | ||
| Q3 24 | $23.3M | $-92.0M | ||
| Q2 24 | $12.1M | $-93.0M | ||
| Q1 24 | $-14.6M | $-4.0M |
营业利润率NREFRCUS
| Q4 25 | — | -1036.4% | ||
| Q3 25 | — | -2366.7% | ||
| Q2 25 | — | -100.0% | ||
| Q1 25 | — | -1525.0% | ||
| Q4 24 | — | -447.8% | ||
| Q3 24 | — | -1500.0% | ||
| Q2 24 | — | -963.6% | ||
| Q1 24 | — | -160.0% |
净利率NREFRCUS
| Q4 25 | 216.6% | -963.6% | ||
| Q3 25 | 407.0% | -2250.0% | ||
| Q2 25 | 184.5% | — | ||
| Q1 25 | 225.6% | -1400.0% | ||
| Q4 24 | 69.9% | -408.7% | ||
| Q3 24 | 186.4% | -1314.3% | ||
| Q2 24 | 179.7% | -845.5% | ||
| Q1 24 | 114.3% | -40.0% |
每股收益（稀释后）NREFRCUS
| Q4 25 | $0.47 | $-0.88 | ||
| Q3 25 | $1.14 | $-1.27 | ||
| Q2 25 | $0.54 | $0.00 | ||
| Q1 25 | $0.70 | $-1.14 | ||
| Q4 24 | $0.71 | $-1.07 | ||
| Q3 24 | $0.74 | $-1.00 | ||
| Q2 24 | $0.40 | $-1.02 | ||
| Q1 24 | $-0.83 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $222.0M |
| 总债务越低越好 | $771.2M | $99.0M |
| 股东权益账面价值 | $388.0M | $631.0M |
| 总资产 | $5.3B | $1.1B |
| 负债/权益比越低杠杆越低 | 1.99× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资NREFRCUS
| Q4 25 | $31.1M | $222.0M | ||
| Q3 25 | $17.9M | $238.0M | ||
| Q2 25 | $9.1M | $248.0M | ||
| Q1 25 | $19.2M | $192.0M | ||
| Q4 24 | $3.9M | $150.0M | ||
| Q3 24 | $34.7M | $201.0M | ||
| Q2 24 | $4.3M | $156.0M | ||
| Q1 24 | $13.5M | $185.0M |
总债务NREFRCUS
| Q4 25 | $771.2M | $99.0M | ||
| Q3 25 | $720.9M | $98.0M | ||
| Q2 25 | $815.6M | $97.0M | ||
| Q1 25 | $831.5M | $48.0M | ||
| Q4 24 | $799.3M | $48.0M | ||
| Q3 24 | $815.5M | $47.0M | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
股东权益NREFRCUS
| Q4 25 | $388.0M | $631.0M | ||
| Q3 25 | $375.4M | $436.0M | ||
| Q2 25 | $348.2M | $549.0M | ||
| Q1 25 | $343.7M | $531.0M | ||
| Q4 24 | $336.5M | $485.0M | ||
| Q3 24 | $335.8M | $565.0M | ||
| Q2 24 | $327.5M | $635.0M | ||
| Q1 24 | $327.1M | $707.0M |
总资产NREFRCUS
| Q4 25 | $5.3B | $1.1B | ||
| Q3 25 | $5.3B | $974.0M | ||
| Q2 25 | $5.4B | $1.1B | ||
| Q1 25 | $5.4B | $1.2B | ||
| Q4 24 | $5.4B | $1.1B | ||
| Q3 24 | $5.7B | $1.3B | ||
| Q2 24 | $6.6B | $1.2B | ||
| Q1 24 | $7.1B | $1.3B |
负债/权益比NREFRCUS
| Q4 25 | 1.99× | 0.16× | ||
| Q3 25 | 1.92× | 0.22× | ||
| Q2 25 | 2.34× | 0.18× | ||
| Q1 25 | 2.42× | 0.09× | ||
| Q4 24 | 2.38× | 0.10× | ||
| Q3 24 | 2.43× | 0.08× | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.5M | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-121.0M |
| 自由现金流率自由现金流/营收 | — | -1100.0% |
| 资本支出强度资本支出/营收 | — | 9.1% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NREFRCUS
| Q4 25 | $-4.5M | $-120.0M | ||
| Q3 25 | $8.1M | $-97.0M | ||
| Q2 25 | $3.3M | $-133.0M | ||
| Q1 25 | $16.0M | $-132.0M | ||
| Q4 24 | $4.4M | $-100.0M | ||
| Q3 24 | $14.7M | $26.0M | ||
| Q2 24 | $-7.5M | $-94.0M | ||
| Q1 24 | $17.7M | $-2.0M |
自由现金流NREFRCUS
| Q4 25 | — | $-121.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-133.0M | ||
| Q4 24 | — | $-101.0M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-6.0M |
自由现金流率NREFRCUS
| Q4 25 | — | -1100.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -1662.5% | ||
| Q4 24 | — | -439.1% | ||
| Q3 24 | — | 357.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -60.0% |
资本支出强度NREFRCUS
| Q4 25 | — | 9.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 12.5% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 40.0% |
现金转化率NREFRCUS
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NREF
暂无分部数据
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
